TY  - JOUR

T1  - Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1

JO  - Value in Health

PY  - 2022/01/01

AU  - Vadgama S

AU  - Mann J

AU  - Bashir Z

AU  - Spooner C

AU  - Collins GP

AU  - Bullement A

ED  - 

DO  - DOI: 10.1016/j.jval.2021.10.015

PB  - Elsevier BV

Y2  - 2025/04/07

ER  -